BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33118037)

  • 1. Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain.
    Prieto-Alhambra D; Balló E; Coma E; Mora N; Aragón M; Prats-Uribe A; Fina F; Benítez M; Guiriguet C; Fàbregas M; Medina-Peralta M; Duarte-Salles T
    Int J Epidemiol; 2021 Jan; 49(6):1930-1939. PubMed ID: 33118037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
    BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study.
    Wang L; Ma H; Yiu KCY; Calzavara A; Landsman D; Luong L; Chan AK; Kustra R; Kwong JC; Boily MC; Hwang S; Straus S; Baral SD; Mishra S
    CMAJ Open; 2020; 8(4):E627-E636. PubMed ID: 33037070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study.
    Leal FE; Mendes-Correa MC; Buss LF; Costa SF; Bizario JCS; de Souza SRP; Thomaz O; Tozetto-Mendoza TR; Villas-Boas LS; de Oliveira-da Silva LC; Grespan RMZ; Capuani L; Buccheri R; Domingues H; Alexander N; Mayaud P; Sabino EC
    BMJ Open; 2021 Jan; 11(1):e042745. PubMed ID: 33436471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain.
    Roel E; Pistillo A; Recalde M; Fernández-Bertolín S; Aragón M; Soerjomataram I; Jenab M; Puente D; Prieto-Alhambra D; Burn E; Duarte-Salles T
    Int J Cancer; 2022 Mar; 150(5):782-794. PubMed ID: 34655476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
    Yazdanpanah Y;
    J Med Virol; 2021 Apr; 93(4):2149-2159. PubMed ID: 33058220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort.
    Reilev M; Kristensen KB; Pottegård A; Lund LC; Hallas J; Ernst MT; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Gubbels S; Krause TG; Mølbak K; Thomsen RW
    Int J Epidemiol; 2020 Oct; 49(5):1468-1481. PubMed ID: 32887982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality.
    Gaipov A; Gusmanov A; Abbay A; Sakko Y; Issanov A; Kadyrzhanuly K; Yermakhanova Z; Aliyeva L; Kashkynbayev A; Moldaliyev I; Crape B; Sarria-Santamera A
    BMC Infect Dis; 2021 May; 21(1):458. PubMed ID: 34016043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans.
    Recalde M; Pistillo A; Fernandez-Bertolin S; Roel E; Aragon M; Freisling H; Prieto-Alhambra D; Burn E; Duarte-Salles T
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5030-e5042. PubMed ID: 34297116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of symptomatic COVID-19 during the first wave in Catalonia.
    Burn E; Tebé C; Fernandez-Bertolin S; Aragon M; Recalde M; Roel E; Prats-Uribe A; Prieto-Alhambra D; Duarte-Salles T
    Nat Commun; 2021 Feb; 12(1):777. PubMed ID: 33536436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.